Key facts
- This page summarizes Robert Levy's Form 3 filing for HERBALIFE LTD. (HLF).
- 0 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 10 Jul 2023, 18:52.
Robert Levy - 01 Jul 2023 Form 3 Insider Report for HERBALIFE LTD. (HLF)
- Reporting relationship
- Regional President - Americas
- Issuer ticker
- HLF
- Reported as of
- 01 Jul 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 10 Jul 2023, 18:52:00 UTC
- Next SEC filing
- 12 May 2026
- Source filing
- View source filing
- Reporting owner signature
- Alaaeddine Sahibi, as Attorney-In-Fact for Robert Levy
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert Levy filed Form 3 for HERBALIFE LTD. (HLF) on 10 Jul 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HLF
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 635,320
- Date
- 01 Jul 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HLF
holding
Derivative
Stock Appreciation Rights
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 39,346
- Exercise price
- $39.79
- Footnotes
- F2
HLF
holding
Derivative
Stock Appreciation Rights
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,030
- Exercise price
- $29.99
- Footnotes
- F3
HLF
holding
Derivative
Stock Appreciation Rights
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 84,828
- Exercise price
- $15.22
- Footnotes
- F4
HLF
holding
Derivative
Stock Appreciation Rights
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 43,668
- Exercise price
- $31.26
- Footnotes
- F5
HLF
holding
Derivative
Stock Appreciation Rights
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 45,902
- Exercise price
- $28.60
- Footnotes
- F6
HLF
holding
Derivative
Stock Appreciation Rights
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 80,049
- Exercise price
- $13.60
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Balance includes 112,152 unvested restricted stock units ("RSUs") previously granted to the Reporting Person, of which: 3,362 were granted on February 19, 2021, of which 20% vested on February 19, 2022, 20% vested on February 19, 2023, and 60% will vest on February 19, 2024; 4,436 were granted on February 25, 2022, of which 20% vested on February 25, 2023, 20% will vest on February 25, 2024, and 60% will vest on February 25, 2025; 94,637 were granted on December 9, 2022 and will vest 100% on December 9, 2024; 11,948 were granted on May 4, 2023, that will vest in 1/3 increments on May 4, 2024, May 4, 2025, and May 4, 2026. All RSU vestings are subject to continued service through each applicable date. Balance also includes 142,740 vested RSUs previously granted to the Reporting Person, which he has elected to defer.
Footnote F2
These stock appreciation rights were fully vested as of June 21, 2016.
Footnote F3
These stock appreciation rights were fully vested as of April 30, 2017.
Footnote F4
These stock appreciation rights were fully vested as of March 2, 2018.
Footnote F5
These stock appreciation rights were fully vested as of May 9, 2019.
Footnote F6
These stock appreciation rights were fully vested as of February 27, 2020.
Footnote F7
On May 4, 2023, the reporting person was granted 80,049 stock appreciation rights that will vest in 1/3 increments on May 4, 2024, May 4, 2025, and May 4, 2026.